Back
Speaker illustration

Professor Bertrand Cariou

Institut du Thorax, Inserm UMR 1087, Nantes (France)

Presentations

Open-label ODYSSEY APPRISE study: interim data from the first 843 participants

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session: Lipids

Access
Like
Thumbnail

Are there effects of PCSK9 inhibitors beyond cholesterol lowering?

Event: ESC Congress 2017

Topic: Lipids

Session: PCSK9 inhibition - cholesterol reduction and beyond

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources